Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disseminated intravascular coagulation.

R L Bick1

  • 1Department of Medicine, University of California, Los Angeles.

Hematology/Oncology Clinics of North America
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contaminants in heparins continue to be unfolded.

International angiology : a journal of the International Union of Angiology·2008
Same author

The rheological changes after cesarean section: The influence of low molecular weight or unfractionated heparin on the rheological properties of blood.

Clinical hemorheology and microcirculation·2007
Same author

Antiphospholipid thrombosis syndromes.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2001
Same author

Stasis ulcers refractory to therapy--accelerated healing by treatment with clopidogrel +/- dalteparin: a preliminary report.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2001
Same author

Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolism.

Drugs·2000
Same author

An update on heparins at the beginning of the new millennium.

Seminars in thrombosis and hemostasis·2000
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Disseminated intravascular coagulation (DIC) involves complex hemostasis system interactions. Understanding these pathophysiologic links is crucial for diagnosing and individually managing DIC, despite ongoing therapeutic controversies.

Area of Science:

  • Hematology
  • Pathophysiology
  • Clinical Medicine

Background:

  • Disseminated intravascular coagulation (DIC) presents with diverse clinical and laboratory findings.
  • Understanding the hemostasis system's interrelationships is key to interpreting DIC manifestations.
  • Many organ-specific syndromes share pathophysiology with DIC but are distinct entities.

Purpose of the Study:

  • To present current concepts on the etiology, pathophysiology, diagnosis, and management of DIC.
  • To highlight the importance of understanding pathophysiologic interrelationships in DIC.
  • To discuss the individualized nature of DIC therapy.

Main Methods:

  • Review of current concepts and literature on DIC.
  • Emphasis on the interrelationships within the hemostasis system.

Related Experiment Videos

  • Discussion of clinical and laboratory findings in DIC patients.

    • Main Results:

    • Clinicians and scientists must understand pathophysiologic interrelationships to interpret DIC findings.
    • Therapeutic decisions for DIC are often controversial and require individualization.
    • DIC shares pathophysiology with various organ-specific syndromes.

    Conclusions:

    • A clear understanding of hemostasis is essential for diagnosing and managing DIC.
    • Individualized therapy is paramount, considering patient-specific factors and DIC characteristics.
    • Further research is needed on specific therapeutic modalities and survival patterns in DIC.